Study of bone gain in Periodontitis patients having bone defect when treated with decortication along with platelet rich fibri
- Registration Number
- CTRI/2020/12/029768
- Lead Sponsor
- MIDSR Dental College Latur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 46
2.Patient diagnosed with stage II and stage III periodontitis as per world workshop jointly held by the American Academy of Periodontology’s and European Federation of Periodontology International Workshop for Classifications of Periodontal Disease 2017.
3.Intrabony defect in both maxillary and mandibular region.
4.Patients having at least one intrabony defect =3 mm along with attendant periodontal pocket depth =5mm and tooth mobility not greater than grade II And Subjects having acceptable systemic health.
5.Participants must have completed initial periodontal therapy scaling root planing consisting of plaque control and good oral hygiene
6.Adequate width of keratinized gingiva should be present.
7.Absence of overt clinical inflammation at the time of surgery.
8.Teeth should be present on both sides of intrabony defects for preparation of stent.
9.Patient signing written informed consent.
1.Medically compromised patients, mentally challenged person.
2.With unacceptable oral hygiene (PI >2)
3.Patients who had received any type of periodontal therapy for the past 6 months with a known history of allergy to Chlorhexidine or any other medicine are used in the study. 4.Patients taking any immuno-suppressive drugs like corticosteroids and with any metabolic disease or endocrine disease having direct or indirect influence on bone healing.
5.Patients with intrabony defects showing radiographic extension beyond the root apices along with positive signs and symptoms of endodontic pathology will be excluded
6.Patient on anticoagulant therapy or with bleeding disorders
7.Patient on active orthodontic treatment and Endodontically treated teeth.
8.Patients with bone disorders and / or who are on bisphosphonate therapy.
9.Pregnant and lactating women.
10.Presence of defective prosthesis in the area of interest.
11.Subjects who are smokers and consume tobacco in any form.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment outcomes of open flap debridement followed by intramarrow penetration along with platelet rich fibrin is better than open flap debridement followed by intramarrow penetration without using platelet rich fibrin as evaluated by changes in clinical parameters.Timepoint: Three months, Six months postsurgey
- Secondary Outcome Measures
Name Time Method reatment outcomes of open flap debridement followed by intramarrow penetration along with platelet rich fibrin is better than open flap debridement followed by intramarrow penetration without using platelet rich fibrin as evaluated by changes in radiographic parameters.Timepoint: Three months, Six months postsurgery